Courtney Phillips
Known title: GC and Corp. SecretaryCIK: 0001782758
Associated companies
Transaction History
| MAZE | ▼ Sell | Open Market | 1,990 | $52K | 9/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 22 | $567 | 9/3/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 1,738 | $46K | 9/2/2026 | View on chart |
| MAZE | ▼ Sell | Open Market | 243 | $7K | 9/2/2026 | View on chart |
| MAZE | ▲ Buy | Option Exercise | 11,000 | $0 | 9/1/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pompe Disease Market Expected to Grow Through 2036
A new market report projects expansion in the Pompe Disease sector from 2026 to 2036, driven by next-generation enzyme replacement therapies and pipeline innovation. This industry growth is relevant to Maze Therapeutics, which operates in this therapeutic area. The report highlights broader market trends rather than company-specific financial results.
Pompe Disease Market Expected to Grow Through 2036. A new market report projects expansion in the Pompe Disease sector from 2026 to 2036, driven by next-generation enzyme replacement therapies and pipeline innovation. This industry growth is relevant to Maze Therapeutics, which operates in this therapeutic area. The report highlights broader market trends rather than company-specific financial results.